Skip to main content

GenMark Borrows $10M Against Debt Facility

NEW YORK (GenomeWeb) – GenMark Diagnostics said in a regulatory document today that it borrowed $10 million against a $40 million debt facility. 

The $10 million was borrowed under an initial term loan pursuant to a debt facility created in January and led by GE Capital's Healthcare Financial Services business. The credit facility comprises a multi-tranched $35 million venture loan facility and a $5 million asset-based revolving credit facility.

GenMark said today in a document filed with the US Securities and Exchange Commission that it is required to pay only the interest on the loan until March 1, 2017, after which it will pay monthly installments of principal and interest until the loan is fully repaid by Jan. 12, 2019. 

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.